LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, et al. Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. 2017;32(3):424–30.

Article  PubMed  Google Scholar 

Roux C, Briot K. The crisis of inadequate treatment in osteoporosis. Lancet Rheumatol. 2020;2(2):e110–9.

Article  Google Scholar 

Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11(3):234–50.

Article  CAS  PubMed  Google Scholar 

Brylka LJ, Schinke T. Chemokines in physiological and pathological bone remodeling. Front Immunol. 2019;10:2182.

Hardy R, Cooper MS. Bone loss in inflammatory disorders. Journal of Endocrinology. 2009;201(3):309–20.

Article  CAS  PubMed  Google Scholar 

Pavanelli ALR, de Menezes BS, Pereira EBB, de Souza Morais FA, Cirelli JA, de Molon RS. Pharmacological therapies for the management of inflammatory bone resorption in periodontal disease: a review of preclinical studies. Biomed Res Int. 2022;2022:5832009.

Article  PubMed  PubMed Central  Google Scholar 

Li G, Li Z, Li L, Liu S, Wu P, Zhou M, et al. Stem cell-niche engineering via multifunctional hydrogel potentiates stem cell therapies for inflammatory bone loss. Adv Funct Mater. 2023;33(2):2209466.

Article  CAS  Google Scholar 

Epsley S, Tadros S, Farid A, Kargilis D, Mehta S, Rajapakse CS. The effect of inflammation on bone. Front Physiol. 2021;11:511799.

Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, et al. Modulation of the inflammatory response and bone healing. Front Endocrinol (Lausanne). 2020;11:386.

Article  PubMed  PubMed Central  Google Scholar 

Batoon L, Millard SM, Raggatt LJ, Pettit AR. Osteomacs and bone regeneration. Curr Osteoporos Rep. 2017;15(4):385–95.

Article  PubMed  Google Scholar 

Walters G, Pountos I, Giannoudis PV. The cytokines and micro-environment of fracture haematoma: current evidence. J Tissue Eng Regen Med. 2018;12(3):e1662–77.

Article  CAS  PubMed  Google Scholar 

Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone. 2007;41(6):928–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerstenfeld L, Cho T-J, Kon T, Aizawa T, Tsay A, Fitch J, et al. Impaired fracture healing in the absence of TNF-α signaling: the role of TNF-α in endochondral cartilage resorption. J Bone Mineral Res. 2003;18(9):1584–92.

Article  CAS  Google Scholar 

Al Farii H, Farahdel L, Frazer A, Salimi A, Bernstein M. The effect of NSAIDs on postfracture bone healing: a meta-analysis of randomized controlled trials. OTA Int. 2021;4(2):e092.

Article  PubMed  PubMed Central  Google Scholar 

Wheatley BM, Nappo KE, Christensen DL, Holman AM, Brooks DI, Potter BK. Effect of NSAIDs on bone healing rates: a meta-analysis. JAAOS J Amer Acad Orthop Surg. 2019;27(7):e330–6.

Lukač N, Katavić V, Novak S, Šućur A, Filipović M, Kalajzić I, et al. What do we know about bone morphogenetic proteins and osteochondroprogenitors in inflammatory conditions? Bone. 2020;137:115403.

Article  PubMed  Google Scholar 

Perrin S, Colnot C. Periosteal skeletal stem and progenitor cells in bone regeneration. Curr Osteoporos Rep. 2022;20(5):334–43.

Article  PubMed  Google Scholar 

Kushioka J, Chow SK, Toya M, Tsubosaka M, Shen H, Gao Q, et al. Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy. Inflamm Regen. 2023;43(1):29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ambrosi TH, Marecic O, McArdle A, Sinha R, Gulati GS, Tong X, et al. Aged skeletal stem cells generate an inflammatory degenerative niche. Nature. 2021;597(7875):256–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferretti C, Lucarini G, Andreoni C, Salvolini E, Bianchi N, Vozzi G, et al. Human periosteal derived stem cell potential: the impact of age. Stem Cell Rev Rep. 2015;11(3):487–500.

Article  CAS  PubMed  Google Scholar 

Durdan MM, Azaria RD, Weivoda MM. Novel insights into the coupling of osteoclasts and resorption to bone formation. Semin Cell Dev Biol. 2022;123:4–13.

Article  CAS  PubMed  Google Scholar 

Xiong J, O’Brien CA. Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res. 2012;27(3):499–505.

Article  CAS  PubMed  Google Scholar 

Kendler DL, Cosman F, Stad RK, Ferrari S. Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Adv Ther. 2022;39(1):58–74.

Article  PubMed  Google Scholar 

Ono T, Hayashi M, Sasaki F, Nakashima T. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020;40(1):2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mbalaviele G, Novack DV, Schett G, Teitelbaum SL. Inflammatory osteolysis: a conspiracy against bone. J Clin Investig. 2017;127(6):2030–9.

Article  PubMed  PubMed Central  Google Scholar 

Walsh MC, Takegahara N, Kim H, Choi Y. Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity. Nat Rev Rheumatol. 2018;14(3):146–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337–42.

Article  CAS  PubMed  Google Scholar 

Hascoët E, Blanchard F, Blin-Wakkach C, Guicheux J, Lesclous P, Cloitre A. New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Res. 2023;11(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Madel M-B, Ibáñez L, Wakkach A, de Vries TJ, Teti A, Apparailly F, et al. Immune function and diversity of osteoclasts in normal and pathological conditions. Front Immunol. 2019;10:1408.

Lapérine O, Blin-Wakkach C, Guicheux J, Beck-Cormier S, Lesclous P. Dendritic-cell-derived osteoclasts: a new game changer in bone-resorption-associated diseases. Drug Discov Today. 2016;21(9):1345–54.

Article  PubMed  Google Scholar 

Hasegawa T, Kikuta J, Sudo T, Matsuura Y, Matsui T, Simmons S, et al. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nat Immunol. 2019;20(12):1631–43.

Article  CAS  PubMed  Google Scholar 

Agemura T, Hasegawa T, Yari S, Kikuta J, Ishii M. Arthritis-associated osteoclastogenic macrophage, AtoM, as a key player in pathological bone erosion. Inflamm Regen. 2022;42(1):17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marahleh A, Kitaura H, Ohori F, Kishikawa A, Ogawa S, Shen W-R, et al. TNF-α directly enhances osteocyte RANKL expression and promotes osteoclast formation. Front Immunol. 2019;10:2925.

Luo G, Li F, Li X, Wang ZG, Zhang B. TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway. Mol Med Rep. 2018;17(5):6605–11.

CAS  PubMed  PubMed Central  Google Scholar 

Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000;106(12):1481–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology. 2002;143(3):1108–18.

Article  CAS  PubMed  Google Scholar 

Xia Y, Inoue K, Du Y, Baker SJ, Reddy EP, Greenblatt MB, et al. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat Commun. 2022;13(1):3920.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, et al. The mechanism of osteoclast differentiation induced by IL-11. J Immunol. 2009;183(3):1862–70.

Article  CAS  PubMed  Google Scholar 

Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y. IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol. 2010;22(10):805–16.

Article  CAS  PubMed  Google Scholar 

Shiratori T, Kyumoto-Nakamura Y, Kukita A, Uehara N, Zhang J, Koda K, et al. IL-1β Induces pathologically activated osteoclasts bearing extremely high levels of resorbing activity: a possible pathological subpopulation of osteoclasts, accompanied by suppressed expression of kindlin-3 and talin-1. J Immunol. 2018;200(1):218–28.

Article  CAS